Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Sees Significant Increase in Short Interest

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) was the target of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 40,613 shares, a growth of 122.6% from the February 12th total of 18,241 shares. Based on an average daily trading volume, of 19,105 shares, the short-interest ratio is presently 2.1 days. Approximately 4.5% of the company’s shares are short sold. Approximately 4.5% of the company’s shares are short sold. Based on an average daily trading volume, of 19,105 shares, the short-interest ratio is presently 2.1 days.

Virtus LifeSci Biotech Clinical Trials ETF Trading Down 1.8%

Shares of NYSEARCA BBC opened at $40.65 on Friday. The business’s 50 day moving average price is $41.13 and its 200-day moving average price is $34.86. Virtus LifeSci Biotech Clinical Trials ETF has a fifty-two week low of $13.42 and a fifty-two week high of $44.10.

About Virtus LifeSci Biotech Clinical Trials ETF

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.